Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track)
NCT ID: NCT02395380
Last Updated: 2017-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
176 participants
INTERVENTIONAL
2015-07-06
2017-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Markers After COloRectal Surgery)
NCT01510314
Role of Procalcitonin, C-Reactive Protein, and WBC Count in Prediction of Colorectal Anastomotic Leak
NCT05159024
Diagnostic Value of C-reactive Protein and White Blood Cell Counts for Early Detection of Inflammatory Complications After Open Resection of Colorectal Cancer
NCT01221324
CRP-guided Transanal Drainage Removal After Rectal Surgery
NCT05502354
Predictive Value of Procalcitonin, CRP, Drain Fluid Culture, Il-6 and Tnf-α in Anastomotic Leakage
NCT02361918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
C-reactive protein dosage
C-reactive protein dosage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-reactive protein dosage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned hospital stay for a colonic resection with anastomosis without permanent or temporary digestive bypass
* Patient with pre-operative CRP lower or egal to 172 mg/L
* No opposition at the participation of the study
* Expected patient return home after surgery (or convalescent home or not medicalized institution)
Exclusion Criteria
* Protected or private patient freedom
* Minor patient
* Colectomy surgery with digestive bypass or digestive anastomosis
* Complex combined surgery (significantly intestinal resection associated, another surgical procedure that can interfere with postoperative CRP)
* General inflammatory disease susceptive to modify dosage values
* Anti-inflammatory therapy (AINS/ corticosteroids/ immunosuppressive)
* Patient unable to understand the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Departemental Vendee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emeric ABET
Role: STUDY_DIRECTOR
Centre Hospitalier Departemental Vendee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Departemental Vendee
La Roche-sur-Yon, , France
CHU Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHD 065-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.